State of New Jersey Common Pension Fund D decreased its stake in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 31.4% in the ...

Kennedy is Trump’s pick for health secretary, but he has a history of spreading misinformation about a range of issues.

His nomination to head the HHS by President-elect Donald Trump on Thursday could bring sweeping changes to the way Washington, D.C., targets health issues.

As previously reported, Wolfe Research initiated coverage of Veracyte (VCYT) with an Outperform rating and $50 price target The genomic ...

Analyst Vikram Purohit of Morgan Stanley maintained a Hold rating on ACELYRIN, INC. (SLRN – Research Report), retaining the price target ...

The findings could reassure policymakers concerned that virtual care could increase unnecessary or wasteful services.

Analysts have set 12-month price targets for Amgen, revealing an average target of $349.0, a high estimate of $405.00, and a ...

Assetmark Inc. boosted its stake in shares of Genmab A/S (NASDAQ:GMAB – Free Report) by 16.2% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 82,629 shares of ...

"Without clear evidence linking previous government action to the expanded list of illnesses — and a price tag north of $50 ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on November 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted non-qualified stock option awards to ...

Several Kansas counties are seeing a dramatic increase in groundwater contamination. The region’s nitrate pollution comes ...